ConcertAI IPO
ConcertAI is a healthcare technology company that uses artificial intelligence and real-world data to accelerate drug development and improve patient outcomes. The company provides AI-powered solutions to pharmaceutical companies, health systems, and life sciences organizations for clinical research and precision medicine.
Key Facts
| Industry | Healthcare AI |
| Founded | 2015 |
| Headquarters | Cambridge, MA |
| Employees | ~500 |
| Website | concertai.com |
| Funding | Series C at $1.9B valuation. Total raised: $415M |
About ConcertAI
ConcertAI operates as a healthcare technology company that leverages artificial intelligence and real-world data to accelerate drug discovery and development. The company has built one of the largest oncology-focused real-world datasets, combining clinical, molecular, and imaging data to help pharmaceutical companies and healthcare providers make better treatment decisions. ConcertAI's platform integrates data from electronic health records, clinical trials, and diagnostic tests to create comprehensive patient profiles that can inform precision medicine approaches. The company has established partnerships with major cancer centers and pharmaceutical companies to expand access to cutting-edge treatments and improve patient outcomes through data-driven insights.
IPO Status
ConcertAI has not announced any plans for an initial public offering. The company has been focused on expanding its AI platform for healthcare and life sciences applications, raising venture capital to fund its growth and technology development. The healthcare AI sector has attracted significant investor interest, but ConcertAI appears to be in a growth phase focused on building its customer base and proving the value of its platform. The company would likely need to demonstrate scalable revenue and clear market leadership before considering public market entry.
Competitors
Frequently Asked Questions
Does ConcertAI have a stock?
No, ConcertAI has not had an IPO and remains a private healthcare AI company. The company has not announced any plans to go public.
When is the ConcertAI IPO date?
There is no confirmed IPO date for ConcertAI, as the company has not announced plans to enter public markets. Any timeline remains speculative.
How can I buy ConcertAI stock?
ConcertAI stock is not available for purchase since the company remains private. Investors would need to wait for a potential IPO announcement.
Stay Updated on the ConcertAI IPO
Get real-time alerts when ConcertAI files for an IPO, prices shares, or begins trading.
Get IPO Alerts